Dr Peter Kent Harman, MD in Oklahoma City, OK - Medicare Critical Care (intensivists)

Dr Peter Kent Harman, MD is a medicare enrolled "Surgery - Surgical Critical Care" physician in Oklahoma City, Oklahoma. He went to University Of Vermont College Of Medicine and graduated in 1978 and has 46 years of diverse experience with area of expertise as Critical Care (intensivists). He is a member of the group practice Halifax Healthcare Systems Inc and his current practice location is 1000 N Lee Ave, Room 4404, Oklahoma City, Oklahoma. You can reach out to his office (for appointments etc.) via phone at (405) 272-6406.

Dr Peter Kent Harman is licensed to practice in Oklahoma (license number 27713) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1285874834.

Contact Information

	Dr Peter Kent Harman, MD
	1000 N Lee Ave, Room 4404, Oklahoma City, OK 73102-1036
	(405) 272-6406
	(405) 272-6075

Physician's Profile

Full Name	Dr Peter Kent Harman
Gender	Male
Speciality	Critical Care (intensivists)
Experience	46 Years
Location	1000 N Lee Ave, Oklahoma City, Oklahoma
Accepts Medicare Assignments	Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.

Medical Education and Training:

Dr Peter Kent Harman attended and graduated from University Of Vermont College Of Medicine in 1978

NPI Data:

NPI Number: 1285874834
Provider Enumeration Date: 02/23/2009
Last Update Date: 05/08/2013

Medicare PECOS Information:

PECOS PAC ID: 2860394418
Enrollment ID: I20101018000014

Medical Identifiers

Medical identifiers for Dr Peter Kent Harman such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1285874834	NPI	-	NPPES
1285874834	Other	FL	TRICARE
149N4	Other	FL	BLUE CROSS BLUE SHIELD OF FLORIDA
002634100	Medicaid	FL

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
2086S0102X	Surgery - Surgical Critical Care	ME103630 (Florida)	Secondary
2086S0102X	Surgery - Surgical Critical Care	27713 (Oklahoma)	Primary

Medical Facilities Affiliation

Facility Name	Location	Facility Type
Halifax Health Medical Center	Daytona beach, FL	Hospital

Group Practice Association

Group Practice Name	Group PECOS PAC ID	No. of Members
Halifax Healthcare Systems Inc	1254238090	278

News Archive

Study analyzes global oncology community's Twitter utilization to enhance discussion at ASCO 2010

JuvoLab, a company focused on value creation in the life sciences industry, today announced the release of a unique study detailing the entire global oncology community's utilization of Twitter to enhance scientific discussion at the ASCO 2010 Annual Meeting. This pioneering study analyzed over 4450 tweets, generated by more than 680 users over the course of the conference, and provides clarity and insight into the use of Twitter from breaking clinical news and engaging in clinical discussion to compliant corporate promotion by industry leaders.

Intrathecal drug delivery cost effective for chronic pain treatments

Estimates of pain care treatment costs exceed $1 billion annually in the United States. Today at the American Academy of Pain Medicine's 26th Annual Meeting two abstracts looked at the issue. One evaluated intrathecal drug delivery (a targeted medicine delivery system) that could save costs over time. The other analyzed the differences between the costs of treatment for chronic pain treatments.

Loyola receives Special Innovation Award for developing self-serve clinical research database

Loyola University Chicago Stritch School of Medicine has received a $6,000 Special Innovation Award for developing a user-friendly, self-serve clinical research database that will help physicians and scientists conduct groundbreaking medical research.

Oncology drug development services: an interview with Dr. Jean-Pierre Wery, President of Crown Bioscience, Inc.

Crown serves pharmaceutical companies and biotech companies. We have two areas of focus: oncology and metabolic diseases. In the oncology space we focus on pre-clinical services. Essentially, we have all the tools to help our customers move from target discovery, target validation, to a clinical candidate.

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Dr Peter Kent Harman allows following entities to bill medicare on his behalf.

Entity Name	Halifax Healthcare Systems Inc
Entity Type	Part B Supplier - Clinic/group Practice
Entity Identifiers	NPI Number: 1245283530 PECOS PAC ID: 1254238090 Enrollment ID: O20031218000443

News Archive

Study analyzes global oncology community's Twitter utilization to enhance discussion at ASCO 2010

Intrathecal drug delivery cost effective for chronic pain treatments

Loyola receives Special Innovation Award for developing self-serve clinical research database

Oncology drug development services: an interview with Dr. Jean-Pierre Wery, President of Crown Bioscience, Inc.

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Peter Kent Harman is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Dr Peter Kent Harman, MD 1000 N Lee Ave, Room 4404, Oklahoma City, OK 73102-1036 Ph: (405) 272-6406	Dr Peter Kent Harman, MD 1000 N Lee Ave, Room 4404, Oklahoma City, OK 73102-1036 Ph: (405) 272-6406

News Archive

Study analyzes global oncology community's Twitter utilization to enhance discussion at ASCO 2010

Intrathecal drug delivery cost effective for chronic pain treatments

Loyola receives Special Innovation Award for developing self-serve clinical research database

Oncology drug development services: an interview with Dr. Jean-Pierre Wery, President of Crown Bioscience, Inc.

Surgery Doctors in Oklahoma City, OK

Dr. Beverly Jean Talbert, M.D. Surgery Medicare: Not Enrolled in Medicare Practice Location: 825 Ne 10th St, Oupb5350, Oklahoma City, OK 73104 Phone: 405-271-4864 Fax: 405-271-1643
Michael Taylor Heath, MD Surgery Medicare: Not Enrolled in Medicare Practice Location: 800 Stanton L Young Blvd, Oklahoma City, OK 73104 Phone: 405-271-6308
Dr. Teresa Marie Shavney, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 3400 Nw Expressway, Suite 420, Oklahoma City, OK 73112 Phone: 405-713-9935 Fax: 405-713-9936
Dr. Mary Kathleen Lindemuth, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 10900 Hefner Pointe Dr, Oklahoma City, OK 73120 Phone: 405-552-0400 Fax: 405-752-4251
John Stephen Chaffin, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 3433 Nw 56th St, Ste 760, Oklahoma City, OK 73112 Phone: 405-951-4345 Fax: 405-951-4392
Juan Claros-sorto, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 920 Sl Young Blvd, Oklahoma City, OK 73104 Phone: 405-271-6308
Ananth Srinivasan, MBBS Surgery Medicare: Accepting Medicare Assignments Practice Location: 3300 Nw Expressway, Oklahoma City, OK 73112 Phone: 405-949-3349 Fax: 405-945-5467

Dr Peter Kent Harman, MD - Medicare Critical Care (intensivists) in Oklahoma City, OK

Contact Information

Physician's Profile

Medical Identifiers

Medical Taxonomies and Licenses

Medical Facilities Affiliation

Group Practice Association

Study analyzes global oncology community's Twitter utilization to enhance discussion at ASCO 2010

Intrathecal drug delivery cost effective for chronic pain treatments

Loyola receives Special Innovation Award for developing self-serve clinical research database

Oncology drug development services: an interview with Dr. Jean-Pierre Wery, President of Crown Bioscience, Inc.

Medicare Reassignments

Study analyzes global oncology community's Twitter utilization to enhance discussion at ASCO 2010

Intrathecal drug delivery cost effective for chronic pain treatments

Loyola receives Special Innovation Award for developing self-serve clinical research database

Oncology drug development services: an interview with Dr. Jean-Pierre Wery, President of Crown Bioscience, Inc.

Medicare Part D Prescriber Enrollment

Mailing Address and Practice Location

Study analyzes global oncology community's Twitter utilization to enhance discussion at ASCO 2010

Intrathecal drug delivery cost effective for chronic pain treatments

Loyola receives Special Innovation Award for developing self-serve clinical research database

Oncology drug development services: an interview with Dr. Jean-Pierre Wery, President of Crown Bioscience, Inc.

Surgery Doctors in Oklahoma City, OK